These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. In vitro expression demonstrates impaired secretion of the gammaAsn319, Asp320 deletion variant fibrinogen. Kani S; Terasawa F; Lord ST; Tozuka M; Ota H; Okumura N; Katsuyama T Thromb Haemost; 2005 Jul; 94(1):53-9. PubMed ID: 16113784 [TBL] [Abstract][Full Text] [Related]
5. Heterozygous variant fibrinogen γA289V (Kanazawa III) was confirmed as hypodysfibrinogenemia by plasma and recombinant fibrinogens. Kaido T; Yoda M; Kamijo T; Taira C; Higuchi Y; Okumura N Int J Lab Hematol; 2020 Apr; 42(2):190-197. PubMed ID: 31957968 [TBL] [Abstract][Full Text] [Related]
6. A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia. Fujihara N; Haneishi A; Yamauchi K; Terasawa F; Ito T; Ishida F; Okumura N Thromb Haemost; 2010 Aug; 104(2):213-23. PubMed ID: 20589319 [TBL] [Abstract][Full Text] [Related]
7. Recombinant γY278H Fibrinogen Showed Normal Secretion from CHO Cells, but a Corresponding Heterozygous Patient Showed Hypofibrinogenemia. Kamijo T; Kaido T; Yoda M; Arai S; Yamauchi K; Okumura N Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069309 [TBL] [Abstract][Full Text] [Related]
8. Genetic analyses of novel compound heterozygous hypodysfibrinogenemia, Tsukuba I: FGG c.1129+62_65 del AATA and FGG c.1299+4 del A. Mukai S; Nagata K; Ikeda M; Arai S; Sugano M; Honda T; Okumura N Thromb Res; 2016 Dec; 148():111-117. PubMed ID: 27837696 [TBL] [Abstract][Full Text] [Related]
9. Differences in the function and secretion of congenital aberrant fibrinogenemia between heterozygous γD320G (Okayama II) and γΔN319-ΔD320 (Otsu I). Mukai S; Ikeda M; Takezawa Y; Sugano M; Honda T; Okumura N Thromb Res; 2015 Dec; 136(6):1318-24. PubMed ID: 26573395 [TBL] [Abstract][Full Text] [Related]
10. Fibrinogen residue γAla341 is necessary for calcium binding and 'A-a' interactions. Park R; Ping L; Song J; Hong SY; Choi TY; Choi JR; Gorkun OV; Lord ST Thromb Haemost; 2012 May; 107(5):875-83. PubMed ID: 22437918 [TBL] [Abstract][Full Text] [Related]
11. Nonsense-mediated mRNA decay was demonstrated in two hypofibrinogenemias caused by heterozygous nonsense mutations of FGG, Shizuoka III and Kanazawa II. Soya K; Takezawa Y; Okumura N; Terasawa F Thromb Res; 2013 Oct; 132(4):465-70. PubMed ID: 24011387 [TBL] [Abstract][Full Text] [Related]
12. An engineered fibrinogen variant AαQ328,366P does not polymerise normally, but retains the ability to form α cross-links. Park R; Ping L; Song J; Seo JY; Choi TY; Choi JR; Gorkun OV; Lord ST Thromb Haemost; 2013 Feb; 109(2):199-206. PubMed ID: 23224113 [TBL] [Abstract][Full Text] [Related]
13. Analysis of fibrinogen variants at gamma387Ile shows that the side chain of gamma387 and the tertiary structure of the gammaC-terminal tail are important not only for assembly and secretion of fibrinogen but also for lateral aggregation of protofibrils and XIIIa-catalyzed gamma-gamma dimer formation. Kani S; Terasawa F; Yamauchi K; Tozuka M; Okumura N Blood; 2006 Sep; 108(6):1887-94. PubMed ID: 16705085 [TBL] [Abstract][Full Text] [Related]
14. Confirmation of mendelian properties of heterodimeric fibrinogen molecules in a heterozygotic dysfibrinogenemia, "fibrinogen Amarillo," using gprphoresis to differentiate semifibrin molecules from fibrinogen and fibrin. Shainoff JR; Ratnoff OD; Smejkal GB; DiBello PM; Welches WR; Lill H; Mitkevich OV; Periman P Thromb Res; 2001 Jan; 101(2):91-9. PubMed ID: 11342210 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of fibrinogen synthesis and secretion between novel variant fibrinogen, nagakute (gamma305Thr --> Ala), and other variants located in gamma305-308 residues]. Kobayashi T; Takezawa Y; Terasawa F; Okumura N Rinsho Byori; 2012 Sep; 60(9):831-8. PubMed ID: 23157111 [TBL] [Abstract][Full Text] [Related]
16. Evidence that heterodimers exist in the fibrinogen Matsumoto II (gamma308N-->K) proband and participate in fibrin fiber formation. Okumura N; Terasawa F; Fujita K; Fujihara N; Tozuka M; Koh CS Thromb Res; 2002 Aug; 107(3-4):157-62. PubMed ID: 12431483 [TBL] [Abstract][Full Text] [Related]
17. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions. Soya K; Terasawa F; Okumura N Thromb Haemost; 2013 Feb; 109(2):221-8. PubMed ID: 23238100 [TBL] [Abstract][Full Text] [Related]
18. The dimeric Aalpha chain composition of dysfibrinogenemic molecules with mutations at Aalpha 16. Meh DA; Siebenlist KR; Galanakis DK; Bergtrom G; Mosesson MW Thromb Res; 1995 Jun; 78(6):531-9. PubMed ID: 15714754 [TBL] [Abstract][Full Text] [Related]
19. Analysis of fibrinogen gamma-chain truncations shows the C-terminus, particularly gammaIle387, is essential for assembly and secretion of this multichain protein. Okumura N; Terasawa F; Tanaka H; Hirota M; Ota H; Kitano K; Kiyosawa K; Lord ST Blood; 2002 May; 99(10):3654-60. PubMed ID: 11986220 [TBL] [Abstract][Full Text] [Related]
20. Recombinant γT305A fibrinogen indicates severely impaired fibrin polymerization due to the aberrant function of hole 'A' and calcium binding sites. Ikeda M; Kobayashi T; Arai S; Mukai S; Takezawa Y; Terasawa F; Okumura N Thromb Res; 2014 Aug; 134(2):518-25. PubMed ID: 24968960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]